AGEAS SA/NV financials
AGEAS SA/NV
5493005DJBML6LY3RV36 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | €10.38B | €13.77B |
| Other income | €296.0M | €282.0M |
| Employee benefits expense | €922.0M | €852.0M |
| Finance costs | €187.0M | €138.0M |
| Profit before tax | €1.45B | €1.23B |
| Income tax expense | €229.0M | €215.0M |
| Profit for the year | €1.22B | €1.02B |
| — attributable to owners | €1.01B | €845.0M |
| — attributable to NCI | €212.0M | €171.0M |
| Total comprehensive income | -€4.47B | €1.10B |
| Per share | ||
| Basic EPS | €5.49 | €4.52 |
| Diluted EPS | €5.48 | €4.52 |
| Free cash flow / share | €-3.06 | €-4.96 |
| Cash flow statement | ||
| Net cash from operating activities | -€588.0M | -€1.06B |
| Net cash from investing activities | €1.03B | €1.44B |
| Purchase of PP&E (capex) | €96.0M | €50.0M |
| Purchase of intangibles | €68.0M | €97.0M |
| Net cash from financing activities | -€1.13B | -€684.0M |
| Dividends paid | €1.03B | €625.0M |
| Balance sheet | ||
| Total assets | €100.30B | €111.14B |
| Property, plant & equipment | €2.23B | €1.73B |
| Intangible assets & goodwill | €1.56B | €1.32B |
| Cash & equivalents | €1.15B | €1.94B |
| Total equity | €8.63B | €14.17B |
| — attributable to owners | €7.58B | €11.91B |
| Non-controlling interests | €1.05B | €2.26B |
| Deferred tax liabilities | €398.0M | €971.0M |
| Derived metrics | ||
| Free cash flow | -€684.0M | -€1.11B |
| Net margin | 11.8% | 7.4% |
| Return on equity | 14.2% | 7.2% |
| Cash conversion ratio | -0.48× | -1.05× |
| Capex coverage | -6.13× | -21.30× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €876.0M | €833.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €167.0M | €41.0M |
| Adjustments For Provisions | -€6.0M | -€15.0M |
| Adjustments For Reconcile Profit Loss | €81.0M | €209.0M |
| Adjustments For Sharebased Payments | €3.0M | €7.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €261.0M | €464.0M |
| Borrowings | €3.81B | €3.62B |
| Cash and Cash Equivalents Classified As Part of Disposal Group Held For Sale | €89.0M | — |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.24B | €1.94B |
| Changes In Other Provisions | €6.0M | €15.0M |
| Claims and Benefits Paid Net of Reinsurance Recoveries | €7.48B | €7.47B |
| Comprehensive Income Attributable To Noncontrolling Interests | -€1.01B | €183.0M |
| Comprehensive Income Attributable To Owners of Parent | -€3.46B | €918.0M |
| Current Tax Assets | €138.0M | €53.0M |
| Current Tax Liabilities | €31.0M | €16.0M |
| Deferred Tax Assets | €918.0M | €100.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €765.0M | €485.0M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €268.0M | €140.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €3.00 | — |
| Dividends Received Classified As Operating Activities | €184.0M | €219.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€16.0M | €6.0M |
| Equity and Liabilities | €100.30B | €111.14B |
| Expense By Nature | €8.93B | €12.54B |
| Expenses Arising From Reinsurance Held | €466.0M | €460.0M |
| Fee and Commission Expense | €1.14B | €1.21B |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €167.0M | €41.0M |
| Income Tax Relating To Availableforsale Financial Assets of Other Comprehensive Income | -€1.66B | -€161.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €61.0M | €34.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €197.0M | €263.0M |
| Increase Decrease In Provision For Unearned Premium | -€43.0M | -€14.0M |
| Increase Decrease Through Sharebased Payment Transactions | -€1.0M | -€1.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €42.0M | -€27.0M |
| Increase Decrease Through Treasury Share Transactions | -€91.0M | -€52.0M |
| Interest Paid Classified As Operating Activities | €162.0M | €142.0M |
| Interest Received Classified As Operating Activities | €1.85B | €1.84B |
| Investment Accounted For Using Equity Method | €4.91B | €5.33B |
| Investment Property | €3.03B | €3.12B |
| Investments For Risk of Policyholders | €15.79B | €18.90B |
| Issue of Equity | — | €2.0M |
| Liabilities | €91.67B | €96.97B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €3.93B | — |
| Net Earned Premium | €8.51B | €8.53B |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €4.21B | €19.0M |
| Other Comprehensive Income | -€5.69B | €85.0M |
| Other Comprehensive Income Attributable To Noncontrolling Interests | -€1.22B | €12.0M |
| Other Comprehensive Income Before Tax Availableforsale Financial Assets | -€7.08B | -€298.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €263.0M | €131.0M |
| Other Comprehensive Income Net of Tax Availableforsale Financial Assets | -€5.42B | -€137.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €15.0M | €291.0M |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | -€5.91B | -€303.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €202.0M | €97.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€5.89B | -€12.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €202.0M | €97.0M |
| Other Expense By Nature | €1.41B | €1.27B |
| Other Fee and Commission Income | €437.0M | €467.0M |
| Payments To Acquire Or Redeem Entitys Shares | €91.0M | €56.0M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €6.0M | — |
| Proceeds From Sales of Investment Property | €449.0M | €177.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €21.0M | €24.0M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €9.25B | €6.55B |
| Provisions | €71.0M | €182.0M |
| Purchase of Financial Instruments Classified As Investing Activities | €7.88B | €4.75B |
| Purchase of Investment Property | €162.0M | €377.0M |
| Revenue From Insurance Contracts Issued Without Reduction For Reinsurance Held | €8.93B | €8.98B |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Net of Tax | -€490.0M | -€168.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €261.0M | €464.0M |
| Subordinated Liabilities | €2.52B | €2.75B |
Every line item above is a fact tagged in AGEAS SA/NV's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.